Crescent Biopharma (GYRE) Stock Price & Financial Analysis
Crescent Biopharma Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Crescent Biopharma
What is the current stock price for GYRE?
As of the latest trading session, GYRE stock trades at $6.48. The 52-week range is $5.44–$9.42, with a day range of $6.14–$6.68.
What is the P/E ratio for GYRE?
The P/E ratio (Price-to-Earnings) for GYRE is shown in the Key Statistics section. This valuation metric helps compare Crescent Biopharma, Inc. to industry peers.
Does GYRE pay dividends?
Crescent Biopharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for GYRE?
Analyst ratings and recommendations for GYRE are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of GYRE?
Crescent Biopharma's market capitalization is $591.9M, classifying it as a small-cap company. Crescent Biopharma operates in the Healthcare sector within the Biotechnology industry.